S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Critical asset just had biggest fall on record (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Critical asset just had biggest fall on record (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double

IM Cannabis (IMCC) Stock Forecast & Price Target

$0.37
+0.06 (+19.35%)
(As of 02/20/2024 ET)

IM Cannabis Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

N/A

TypeCurrent Forecast
2/21/23 to 2/21/24
1 Month Ago
1/22/23 to 1/22/24
3 Months Ago
11/23/22 to 11/23/23
1 Year Ago
2/21/22 to 2/21/23
Consensus Rating
Hold
Hold
Hold
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
N/A
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price TargetN/AN/AN/A$13.75
Predicted UpsideN/AN/AN/A161.36% Upside
Get IM Cannabis Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter.


IMCC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IMCC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

IM Cannabis Stock vs. The Competition

TypeIM CannabisMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.67
2.48
Consensus RatingHoldModerate BuyHold
Predicted Upside917.80% Upside8.95% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/30/2023Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:45 AM ET.












IMCC Price Target - Frequently Asked Questions

What is IM Cannabis's consensus rating?

According to the issued ratings of 1 analysts in the last year, the consensus rating for IM Cannabis stock is Hold based on the current 1 hold rating for IMCCthe . Learn more on IMCC's analyst rating history.

Do Wall Street analysts like IM Cannabis more than its competitors?

Analysts like IM Cannabis less than other Medical companies. The consensus rating for IM Cannabis is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how IMCC compares to other companies.


Stock Ratings Reports and Tools

This page (NASDAQ:IMCC) was last updated on 2/21/2024 by MarketBeat.com Staff